SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-I/A - Tender offer statement by Issuer: [Amend]
SEC Accession No. 0001341004-10-001058
Filing Date
2010-06-18
Accepted
2010-06-18 15:53:40
Documents
4

Document Format Files

Seq Description Document Type Size
1 osi_sctoia.htm SC TO-I/A 56575
2 EXHIBIT (A)(5)(A) -- 2% NOTES FUNDAMENTAL CHANGE COMPANY NOTICE AND NOTICE OF CO ex-a5a.htm EX-99.(A)(5)(A) 48976
3 EXHIBIT (A)(5)(B) -- PRESS RELEASE OF THE COMPANY RELATING TO OCCURRENCE OF A FU ex-a5b.htm EX-99.(A)(5)(B) 15270
4 logo1.jpg GRAPHIC 7705
  Complete submission text file 0001341004-10-001058.txt   133676
Mailing Address 41 PINELAWN ROAD MELVILLE NY 11747
Business Address 41 PINELAWN ROAD MELVILLE NY 11747 631-962-2000
OSI PHARMACEUTICALS INC (Filed by) CIK: 0000729922 (see all company filings)

IRS No.: 133159796 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-I/A
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 41 PINELAWN ROAD MELVILLE NY 11747
Business Address 41 PINELAWN ROAD MELVILLE NY 11747 631-962-2000
OSI PHARMACEUTICALS INC (Subject) CIK: 0000729922 (see all company filings)

IRS No.: 133159796 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-I/A | Act: 34 | File No.: 005-37954 | Film No.: 10905874
SIC: 2835 In Vitro & In Vivo Diagnostic Substances